CDK6 and cancer: An analysis of the genetic dependency data across 1070 cancer cell lines from the Cancer Dependency Map (DepMap) project has revealed that CDK12 is essential in close to 30% of cancer cell lines, of which average knockout effects on cell viability were similar to those of the cell-cycle oncogenes CDK4 and CDK6 (20).